Variant Capture Maps for Protein Residue Interaction Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods face challenges in understanding and predicting the impact of genetic variants on human health due to incomplete information about the relationship between genetic variants and phenotypes, particularly in capturing key residue interactions disrupted by disease-triggering variants, which hinders the development of precise therapeutic strategies.
Innovation Solution
The Variation Capture (VarC) method uses spatial covariance-based triangulation (SCVT) to estimate clinical, biological, and chemical properties of protein variants, generating visualizations that combine 3D distance and pairwise covariance to predict the impact of genetic variations on protein function and structure, facilitating the design of therapeutic solutions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If cryo-EM is used to detect and model small-molecule interactions with proteins, then the ability to reveal molecular features of therapeutics is improved, but the ability to capture key residue interactions disrupted by genetic variants deteriorates
Solution Approach 1:
The patent introduces a computational intermediary (in silico mutagenesis and free energy perturbation calculations) that mediates between the experimental cryo-EM data and the interpretation of residue interactions. This computational layer allows indirect detection of disrupted residue interactions by comparing wild-type and variant protein behaviors, overcoming the limitation of direct experimental observation.
Solution Approach 2:
The patent creates computational copies of the protein system through in silico mutagenesis, generating virtual models of variant proteins that preserve the key interactions of interest. These computational copies allow repeated analysis of residue interactions without requiring additional experimental measurements, enabling thorough investigation of disrupted interactions.
2Measurement precision
If high-resolution structure determination is used to reveal molecular features, then the understanding of small-molecule therapeutic mechanisms is improved, but the characterization of variants with disrupted fold thermodynamics deteriorates
Solution Approach 1:
The patent replaces the mechanical/experimental system (biochemical and biophysical characterization) with a computational system (free energy perturbation calculations and molecular dynamics simulations). This substitution allows reliable characterization of variants with disrupted fold thermodynamics by computing free energy differences and stability changes without requiring experimental measurements that fail for unstable variants.
Solution Approach 2:
The patent changes the measurement parameters from experimental observables (which become unreliable for disrupted variants) to computational parameters (free energy differences, stability metrics). By transforming the problem into the computational domain, the patent maintains reliability for characterizing variants that would otherwise be intractable experimentally.
3Loss of information
If complete information about genotype-phenotype relationships is pursued, then the precision of therapeutic strategies is improved, but the complexity of data analysis and visualization deteriorates
Solution Approach 1:
The patent segments the complex genotype-phenotype data into distinct functional components: covariance networks, 3D structural projections, and variant impact classifications. By dividing the comprehensive data set into organized segments, the system maintains complete information while reducing analysis complexity through structured presentation and focused visualization of specific relationship types.
Solution Approach 2:
The patent transforms complex multivariate genotype-phenotype data into visual representations across multiple dimensions: covariance strength (intensity), spatial distance (position), and functional impact (color coding). This dimensional transformation allows complete information to be conveyed through intuitive visual patterns that reduce analytical complexity while preserving comprehensive relationships.
Data Source
AI summary
Drug discovery methodologies are enhanced through the use of variant capture maps that provide visualizations of functional covariance between different amino acids of a protein. These variant capture maps can be filtered with 3D distance data and overlapped to provide a rich source of information regarding sequence, structure, and function of a protein to assist development of treatment compounds and protocols.